Sean E. Quinn - 15 Feb 2024 Form 4 Insider Report for CIMPRESS plc (CMPR)

Role
EVP, Chief Financial Officer
Signature
/s/Kathryn L. Leach, as attorney-in-fact for Sean E. Quinn
Issuer symbol
CMPR
Transactions as of
15 Feb 2024
Net transactions value
-$384,844
Form type
4
Filing time
15 Feb 2024, 17:38:50 UTC
Previous filing
01 Feb 2024
Next filing
15 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMPR Ordinary Shares Options Exercise $0 +9,977 $0.000000 9,977 15 Feb 2024 Direct F1
transaction CMPR Ordinary Shares Options Exercise $0 +2,300 +23% $0.000000 12,277 15 Feb 2024 Direct F1
transaction CMPR Ordinary Shares Tax liability $384,844 -4,277 -35% $89.98 8,000 15 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMPR Restricted Share Units (right to acquire) Options Exercise $0 -9,977 -50% $0.000000 9,977 15 Feb 2024 Ordinary Shares 9,977 $0.000000 Direct F1, F2
transaction CMPR Restricted Share Units (right to acquire) Options Exercise $0 -2,300 -9.1% $0.000000 22,997 15 Feb 2024 Ordinary Shares 2,300 $0.000000 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares acquired represent the number of shares that automatically vested pursuant to an award of restricted share units (RSUs). Each RSU represents Cimpress' commitment to issue one ordinary share.
F2 These RSUs vest over a three year period: one-third of the original number of shares vest on the Date Exercisable in Table II and one-third vest per year thereafter.
F3 These RSUs vest over a four-year period: 25% of the original number of shares vest on the Exercisable Date shown in Table II and 6.25% vest at the end of each successive three-month period thereafter.